華置(00127.HK)累沽共1.09億股恆大(03333.HK)套2.5億元 且擬悉售餘下持股
華人置業(00127.HK)公布,自今年8月30日至9月21日期間,出售共1.09億股中國恆大(03333.HK)股份,佔恆大已發行股本約0.82%,總代價約為2.47億元,每股平均售價約為2.26元。
華置於出售事項後繼續持有約7.51億股恆大股份,佔後者已發行股本約5.66%。集團將視乎當時市況,計劃於授權期間(即今年9月23日起計12個月期間有效)出售餘下全部或部分授權股份。
假設集團已於2021年根據出售授權出售所有授權股份,估計集團將於截至今年12月底止年度於其他全面收益錄得已變現虧損約94.86億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.